Evidence map›Paper›PMID 42102379›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Heterojunction-Engineered Mass Spectrometry Platform for Deciphering Serum Metabolic Fingerprints in Diagnosis of Respiratory Diseases.

Junyu Chen, Chaoqi Wang, Xi Yu, Yuming Jiang, Yijiao Qu, Huihui Fu, Yuyin Bu, Xiaoyong Zhang, Zongxiu Nie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Junyu ChenJiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center For Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Chaoqi WangJiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center For Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Xi YuBeijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry For Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
Yuming JiangDepartment of Computational Biomedicine, Smidt Heart Institute, and Advanced Clinical Biosystems Research Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.
Yijiao QuBeijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry For Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
Huihui FuJiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center For Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yuyin BuJiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center For Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Xiaoyong ZhangDepartment of Chemistry, Nanchang University, Nanchang, China.
Zongxiu NieBeijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry For Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.

Funding

Incubation Program of the Second Affiliated Hospital of Nanchang University 2023YNFY12040Jiangxi Provincial Health Commission Science and Technology Plan Project Youth Project 202510374Jiangxi Provincial Natural Science Foundation 20242BAB20431National Natural Sciences Foundation of China 82402752
6 · The paper itself

Abstract

Respiratory diseases, including bronchial asthma (BA), chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), and lung cancer (LCa), pose a major global health challenge due to overlapping symptoms that frequently delay accurate diagnosis. Although metabolomics-based molecular phenotyping offers a promising path forward, its application in clinical treatment is limited by the use of conventional analytical techniques. Herein, MOF-derived metal oxide/TiO

Indexed as

Mass SpectrometryMetabolomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBiomarkersHumansBiomarkersdisease diagnosislaser desorption/ionization mass spectrometrymetabolic profilingmetal–organic framework hybridsrespiratory diseases

Identifiers

PMID42102379
PMCPMC13335958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.